Initial survival outcomes for the AGITG GAP study a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)

Andrew P. Barbour; Nicholas O'Rourke; Howard Chan; YuJo Chua; James Kench; Rodney J. Hicks; Jaswinder S Samra; N. Pavlakis; Koroush Haghighi; Sonia Yip; Mark Donoghoe

doi:10.1200/JCO.2016.34.15_suppl.4105

Initial survival outcomes for the AGITG GAP study a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)

Andrew P. Barbour, Nicholas O'Rourke, Howard Chan, YuJo Chua, James Kench, Rodney J. Hicks, Jaswinder S Samra, N. Pavlakis, Koroush Haghighi, Sonia Yip, Mark Donoghoe

Research output: Contribution to journal › Literature review

Original language	English
Pages (from-to)	Abstract Number: 4105
Journal	Journal of Clinical Oncology
Volume	34
Issue number	Supplement 5
DOIs	https://doi.org/10.1200/JCO.2016.34.15_suppl.4105
Publication status	Published - 2016

Access to Document

10.1200/JCO.2016.34.15_suppl.4105

Cite this

Barbour, A. P., O'Rourke, N., Chan, H., Chua, Y., Kench, J., Hicks, R. J., Samra, J. S., Pavlakis, N., Haghighi, K., Yip, S., & Donoghoe, M. (2016). Initial survival outcomes for the AGITG GAP study a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC). Journal of Clinical Oncology, 34(Supplement 5), Abstract Number: 4105. https://doi.org/10.1200/JCO.2016.34.15_suppl.4105

@article{02c2eec666614b2183793ec755d989ac,

title = "Initial survival outcomes for the AGITG GAP study a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)",

author = "Barbour, {Andrew P.} and Nicholas O'Rourke and Howard Chan and YuJo Chua and James Kench and Hicks, {Rodney J.} and Samra, {Jaswinder S} and N. Pavlakis and Koroush Haghighi and Sonia Yip and Mark Donoghoe",

year = "2016",

doi = "10.1200/JCO.2016.34.15_suppl.4105",

language = "English",

volume = "34",

pages = "Abstract Number: 4105",

journal = "Journal of Clinical Oncology",

publisher = "American Society of Clinical Oncology",

number = "Supplement 5",

}

Barbour, AP, O'Rourke, N, Chan, H, Chua, Y, Kench, J, Hicks, RJ, Samra, JS, Pavlakis, N, Haghighi, K, Yip, S & Donoghoe, M 2016, 'Initial survival outcomes for the AGITG GAP study a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)', Journal of Clinical Oncology, vol. 34, no. Supplement 5, pp. Abstract Number: 4105. https://doi.org/10.1200/JCO.2016.34.15_suppl.4105

Initial survival outcomes for the AGITG GAP study a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC). / Barbour, Andrew P.; O'Rourke, Nicholas; Chan, Howard et al.
In: Journal of Clinical Oncology, Vol. 34, No. Supplement 5, 2016, p. Abstract Number: 4105.

Research output: Contribution to journal › Literature review

TY - JOUR

T1 - Initial survival outcomes for the AGITG GAP study a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)

AU - Barbour, Andrew P.

AU - O'Rourke, Nicholas

AU - Chan, Howard

AU - Chua, YuJo

AU - Kench, James

AU - Hicks, Rodney J.

AU - Samra, Jaswinder S

AU - Pavlakis, N.

AU - Haghighi, Koroush

AU - Yip, Sonia

AU - Donoghoe, Mark

PY - 2016

Y1 - 2016

U2 - 10.1200/JCO.2016.34.15_suppl.4105

DO - 10.1200/JCO.2016.34.15_suppl.4105

M3 - Literature review

VL - 34

SP - Abstract Number: 4105

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - Supplement 5

ER -